Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Change in Receivables (2021 - 2025)

Core Scientific (CORZW) has disclosed Change in Receivables for 5 consecutive years, with -$6000.0 as the latest value for Q1 2025.

  • Quarterly Change in Receivables fell 105.66% to -$6000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$112000.0 through Mar 2025, down 177.78% year-over-year, with the annual reading at -$23000.0 for FY2023, 100.29% down from the prior year.
  • Change in Receivables hit -$6000.0 in Q1 2025 for Core Scientific, up from -$3.7 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $16.1 million in Q2 2021 to a low of -$16.1 million in Q3 2021.
  • Historically, Change in Receivables has averaged $488187.5 across 5 years, with a median of $40500.0 in 2021.
  • Biggest YoY gain for Change in Receivables was 9292.11% in 2024; the steepest drop was 509.24% in 2024.
  • Year by year, Change in Receivables stood at $39000.0 in 2021, then soared by 2769.23% to $1.1 million in 2022, then tumbled by 180.25% to -$898000.0 in 2023, then plummeted by 309.24% to -$3.7 million in 2024, then surged by 99.84% to -$6000.0 in 2025.
  • Business Quant data shows Change in Receivables for CORZW at -$6000.0 in Q1 2025, -$3.7 million in Q3 2024, and $3.6 million in Q2 2024.